REFERENCES
1. Wong J, Goh QY, Tan Z, Lie SA, Tay YC, Ng SY, et al. Preparing for a
COVID-19 pandemic: a review of operating room outbreak response measures
in a large tertiary hospital in Singapore. Can J Anaesth. 2020.
2. Wang X, Zhang X, He J. Challenges to the system of reserve medical
supplies for public health emergencies: reflections on the outbreak of
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
epidemic in China. Biosci Trends. 2020;14(1):3-8.
3. MacIntyre CR, Chughtai AA, Seale H, Richards GA, Davidson PM.
Respiratory protection for healthcare workers treating Ebola virus
disease (EVD): are facemasks sufficient to meet occupational health and
safety obligations? Int J Nurs Stud. 2014;51(11):1421-6.
4. Chughtai AA, Seale H, MacIntyre CR. Availability, consistency and
evidence-base of policies and guidelines on the use of mask and
respirator to protect hospital health care workers: a global analysis.
BMC Res Notes. 2013;6:216.
5. Australian Health Management Plan for Pandemic Influenza. Australian
Government Department of Health. August 2019.
6. Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber
GE. Effectiveness of N95 respirators versus surgical masks in protecting
health care workers from acute respiratory infection: a systematic
review and meta-analysis. Cmaj. 2016;188(8):567-74.
7. Long Y, Hu T, Liu L, Chen R, Guo Q, Yang L, et al. Effectiveness of
N95 respirators versus surgical masks against influenza: A systematic
review and meta-analysis. J Evid Based Med. 2020.
8. CADTH Rapid Response Reports. Respiratory Precautions for Protection
from Bioaerosols or Infectious Agents: A Review of the Clinical
Effectiveness and Guidelines. Ottawa (ON): Canadian Agency for Drugs and
Technologies in Health
Copyright © 2014 Canadian Agency for Drugs and Technologies in Health.;
2014.
9. Chung SJ, Ling ML, Seto WH, Ang BS, Tambyah PA. Debate on MERS-CoV
respiratory precautions: surgical mask or N95 respirators? Singapore Med
J. 2014;55(6):294-7.
10. Guidance on Preparing Workplaces for COVID-19. OSHA. 2020.
11. Rational use of personal protective equipment (PPE) for coronavirus
disease (COVID-19). WHO. 19 March 2020.
12. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid
advice guideline for the diagnosis and treatment of 2019 novel
coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med
Res. 2020;7(1):4.
13. Schwartz J, King CC, Yen MY. Protecting Health Care Workers during
the COVID-19 Coronavirus Outbreak -Lessons from Taiwan’s SARS response.
Clin Infect Dis. 2020.
14. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial
cluster of pneumonia associated with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster.
Lancet. 2020;395(10223):514-23.
15. Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of
infection associated with the 2019 novel coronavirus indicating
potential person-to-person transmission during the incubation period. J
Infect Dis. 2020.
16. Huh S. How to train the health personnel for protecting themselves
from novel coronavirus (COVID-19) infection during their patient or
suspected case care. J Educ Eval Health Prof. 2020;17:10.
17. Brewster DJ, Chrimes NC, Do TB, Fraser K, Groombridge CJ, Higgs A,
et al. Consensus statement: Safe Airway Society principles of airway
management and tracheal intubation specific to the COVID-19 adult
patient group. MJA. 16 March 2020.
18. Phan LT, Sweeney D, Maita D, Moritz DC, Bleasdale SC, Jones RM.
Respiratory viruses on personal protective equipment and bodies of
healthcare workers. Infect Control Hosp Epidemiol. 2019;40(12):1356-60.
19. Yassi A, Moore D, Fitzgerald JM, Bigelow P, Hon CY, Bryce E.
Research gaps in protecting healthcare workers from SARS and other
respiratory pathogens: an interdisciplinary, multi-stakeholder,
evidence-based approach. J Occup Environ Med. 2005;47(1):41-50.
20. Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief
perspective from the front line. J Infect. 2020;80(4):373-7.
21. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A,
Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as
Compared with SARS-CoV-1. N Engl J Med. 2020.
22. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of
coronaviruses on inanimate surfaces and their inactivation with biocidal
agents. J Hosp Infect. 2020;104(3):246-51.
23. Wax RS, Christian MD. Practical recommendations for critical care
and anesthesiology teams caring for novel coronavirus (2019-nCoV)
patients. Can J Anaesth. 2020.
24. Zhang H. Early lessons from the frontline of the 2019-nCoV outbreak.
Lancet. 2020;395(10225):687.
25. Koh D. Occupational risks for COVID-19 infection. Occup Med (Lond).
2020;70(1):3-5.
26. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C,
et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact
in Germany. N Engl J Med. 2020;382(10):970-1.
27. Mizumoto K, Chowell G. Estimating Risk for Death from 2019 Novel
Coronavirus Disease, China, January-February 2020. Emerg Infect Dis.
2020;26(6).
28. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2
Viral Load in Upper Respiratory Specimens of Infected Patients. New
England Journal of Medicine. 2020;382(12):1177-9.
29. Guidance for Health Care Workers Performing Aerosol Generating
Medical Procedures During the COVID-10 Pandemic. CSO-HNS. 26 March 2020.
30. Handbook of COVID-19 Prevention and Treatment. Zhejiang University.
24 March 2020.
31. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G,
et al. COVID-19: towards controlling of a pandemic. Lancet. 2020.
32. Otolaryngologists and the COVID-19 Pandemic. AAOHNS. 23 March 2020.
33. Liu Y, Li J, Feng Y. Critical care response to a hospital outbreak
of the 2019-nCoV infection in Shenzhen, China. Crit Care. 2020;24(1):56.
34. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020.
35. Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et
al. Real-Time Estimation of the Risk of Death from Novel Coronavirus
(COVID-19) Infection: Inference Using Exported Cases. J Clin Med.
2020;9(2).
36. Chao YS, Spry C. CADTH Rapid Response Reports. The Use of N95
Respirators for Protection against Droplet Borne Illness: A Review of
the Clinical Effectiveness and Guidelines. Ottawa (ON): Canadian Agency
for Drugs and Technologies in Health
Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.;
2017.
37. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical
Characteristics of Coronavirus Disease 2019 in China. N Engl J Med.
2020.
38. Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global
epidemiology of coronavirus disease 2019: disease incidence, daily
cumulative index, mortality, and their association with country
healthcare resources and economic status. Int J Antimicrob Agents.
2020:105946.
39. The L. COVID-19: protecting health-care workers. Lancet.
2020;395(10228):922.
40. Rohan P, O’Reilly MK, Gibney B, Nason GJ. Supply of Personal
Protective Equipment (PPE) During the Covid-19 Pandemic. Ir Med J.
2020;113(4):66.
41. Gawande A. Keeping the Coronavirus from Infecting Health-Care
Workers. The New Yorker. 21 MArch 2020.
42. Zhang Z, Yao W, Wang Y, Long C, Fu X. Wuhan and Hubei COVID-19
mortality analysis reveals the critical role of timely supply of medical
resources. J Infect. 2020.
43. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020.
44. Patel ZM, Fernandez-Miranda J, Hwang PH, Nayak JV, Dodd R, Sajjadi
H, et al. Precautions for Endoscopic Transnasal Skull Base Surgery
During the COVID-19 Pandemic. Neurosurg. 2020.
45. Wang X, Pan Z, Cheng Z. Association between 2019-nCoV transmission
and N95 respirator use. J Hosp Infect. 2020.
46. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020;395(10223):497-506.
47. MacIntyre CR, Chughtai AA, Rahman B, Peng Y, Zhang Y, Seale H, et
al. The efficacy of medical masks and respirators against respiratory
infection in healthcare workers. Influenza Other Respir Viruses.
2017;11(6):511-7.
48. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early
Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected
Pneumonia. N Engl J Med. 2020;382(13):1199-207.
49. Caputo KM, Byrick R, Chapman MG, Orser BJ, Orser BA. Intubation of
SARS patients: infection and perspectives of healthcare workers. Can J
Anaesth. 2006;53(2):122-9.
50. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA,
et al. Clinical features and short-term outcomes of 144 patients with
SARS in the greater Toronto area. Jama. 2003;289(21):2801-9.
51. Oh VM, Lim TK. Singapore’s experience of SARS. Clin Med (Lond).
2003;3(5):448-51.
52. Chang, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting
health-care workers from subclinical coronavirus infection. Lancet
Respir Med. 2020;8(3):e13.
53. Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection
control measures in ophthalmology during the novel coronavirus outbreak:
an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020.
54. Wang H, Wang S, Yu K. COVID-19 infection epidemic: the medical
management strategies in Heilongjiang Province, China. Crit Care.
2020;24(1):107.
55. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between
COVID-19 mortality and health-care resource availability. Lancet Glob
Health. 2020;8(4):e480.
56. Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early
recognition and intervention: experience from Jiangsu Province. Ann
Intensive Care. 2020;10(1):33.
57. Roussel Y, Giraud-Gatineau A, Jimeno MT, Rolain JM, Zandotti C,
Colson P, et al. SARS-CoV-2: fear versus data. Int J Antimicrob Agents.
2020:105947.
58. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher
RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality
rate - a word of caution. Swiss Med Wkly. 2020;150:w20203.
59. Wujtewicz M, Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S,
Piwowarczyk S, Owczuk R. COVID-19 – what should anaethesiologists and
intensivists know about it? Anaesthesiology Intensive Therapy.
2020;52(1):34-41.
60. Alice SU. Doctors and nurses fighting coronavirus in China die of
both infection and fatigue. LA Times. 25 February 2020.
61. Santos J. 10 doctors died of COVID-19. GMA News. 28 March 2020.
62. Redazione. Elenco dei Medici caduti nel corso dell’epidemia di
Covid-19. FNOMCeO. 27 March 2020.
63. Phan LT, Maita D, Mortiz DC, Weber R, Fritzen-Pedicini C, Bleasdale
SC, et al. Personal protective equipment doffing practices of healthcare
workers. J Occup Environ Hyg. 2019;16(8):575-81.
64. John A, Tomas ME, Cadnum JL, Mana TS, Jencson A, Shaikh A, et al.
Are health care personnel trained in correct use of personal protective
equipment? Am J Infect Control. 2016;44(7):840-2.
65. Verbeek JH, Rajamaki B, Ijaz S, Tikka C, Ruotsalainen JH, Edmond MB,
et al. Personal protective equipment for preventing highly infectious
diseases due to exposure to contaminated body fluids in healthcare
staff. Cochrane Database Syst Rev. 2019;7:Cd011621.
66. Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of
seasonal influenza-attenuated virus aerosols and the efficacy of n95
respirators, surgical masks, and eye protection in humans. J Infect Dis.
2011;204(2):193-9.
67. Hospital Respiratory Protection Program Toolkit. NIOSH. May 2015.
68. Oberg T, Brosseau LM. Surgical mask filter and fit performance. Am J
Infect Control. 2008;36(4):276-82.
69. Bischoff WE, Turner J, Russell G, Blevins M, Missaiel E, Stehle J.
How well do N95 respirators protect healthcare providers against
aerosolized influenza virus? Infect Control Hosp Epidemiol. 2018:1-3.
70. Interim Infection Prevention and Control Recommendations for
Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19)
in Healthcare Settings. CDC. 19 March 2020.
71. Yaneza M. ENTUK Guidelines for Changes in ENT During COVID-19
Pandemic. ENTUK. 2020.
72. Prunty S, HInton-Bayre A. Western AustralianENTRecommendations for
PPE for Aerosol GeneratingProcedures during COVID-19 Pandemic. 25 March
2020.
73. Malhotra N, Gupta N, Ish S, Ish P. COVID-19 in intensive care. Some
necessary steps for health care workers. Monaldi Arch Chest Dis.
2020;90(1).
74. Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient
needs an operation: operating room preparation and guidance. Can J
Anaesth. 2020.
75. Radonovich LJ, Jr., Cheng J, Shenal BV, Hodgson M, Bender BS.
Respirator tolerance in health care workers. Jama. 2009;301(1):36-8.
76. Roberge RJ. Effect of surgical masks worn concurrently over N95
filtering facepiece respirators: extended service life versus increased
user burden. J Public Health Manag Pract. 2008;14(2):E19-26.
77. Roberge RJ. Evaluation of the rationale for concurrent use of N95
filtering facepiece respirators with loose-fitting powered air-purifying
respirators during aerosol-generating medical procedures. Am J Infect
Control. 2008;36(2):135-41.
78. Rebmann T, Carrico R, Wang J. Physiologic and other effects and
compliance with long-term respirator use among medical intensive care
unit nurses. Am J Infect Control. 2013;41(12):1218-23.
79. Nicolle L. SARS safety and science. Can J Anaesth.
2003;50(10):983-5, 5-8.
80. Casanova L, Rutala WA, Weber DJ, Sobsey MD. Coronavirus survival on
healthcare personal protective equipment. Infect Control Hosp Epidemiol.
2010;31(5):560-1.
81. Coulliette AD, Perry KA, Edwards JR, Noble-Wang JA. Persistence of
the 2009 pandemic influenza A (H1N1) virus on N95 respirators. Appl
Environ Microbiol. 2013;79(7):2148-55.
82. Fisher EM, Shaffer RE. Considerations for recommending extended use
and limited reuse of filtering facepiece respirators in health care
settings. J Occup Environ Hyg. 2014;11(8):D115-28.
83. Lopez GU, Gerba CP, Tamimi AH, Kitajima M, Maxwell SL, Rose JB.
Transfer efficiency of bacteria and viruses from porous and nonporous
fomites to fingers under different relative humidity conditions. Appl
Environ Microbiol. 2013;79(18):5728-34.
84. Rusin P, Maxwell S, Gerba C. Comparative surface-to-hand and
fingertip-to-mouth transfer efficiency of gram-positive bacteria,
gram-negative bacteria, and phage. J Appl Microbiol. 2002;93(4):585-92.
85. Fisher EM, Richardson AW, Harpest SD, Hofacre KC, Shaffer RE.
Reaerosolization of MS2 bacteriophage from an N95 filtering facepiece
respirator by simulated coughing. Ann Occup Hyg. 2012;56(3):315-25.
86. Kennedy NJ, Hinds WC. Release of simulated anthrax particles from
disposable respirators. J Occup Environ Hyg. 2004;1(1):7-10.
87. Birkner JS, Fung D, Hinds WC, Kennedy NJ. Particle release from
respirators, part I: determination of the effect of particle size, drop
height, and load. J Occup Environ Hyg. 2011;8(1):1-9.
88. Phan T. Novel coronavirus: From discovery to clinical diagnostics.
Infect Genet Evol. 2020;79:104211.
89. MacIntyre CR, Wang Q, Seale H, Yang P, Shi W, Gao Z, et al. A
randomized clinical trial of three options for N95 respirators and
medical masks in health workers. Am J Respir Crit Care Med.
2013;187(9):960-6.
90. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, et al.
Surgical mask vs N95 respirator for preventing influenza among health
care workers: a randomized trial. Jama. 2009;302(17):1865-71.
91. Elder AG, O’Donnell B, McCruden EA, Symington IS, Carman WF.
Incidence and recall of influenza in a cohort of Glasgow healthcare
workers during the 1993-4 epidemic: results of serum testing and
questionnaire. Bmj. 1996;313(7067):1241-2.
92. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute
hospital setting. Lancet Infect Dis. 2002;2(3):145-55.
93. MacIntyre CR, Wang Q, Cauchemez S, Seale H, Dwyer DE, Yang P, et al.
A cluster randomized clinical trial comparing fit-tested and
non-fit-tested N95 respirators to medical masks to prevent respiratory
virus infection in health care workers. Influenza Other Respir Viruses.
2011;5(3):170-9.
94. Bergman MS, Viscusi DJ, Zhuang Z, Palmiero AJ, Powell JB, Shaffer
RE. Impact of multiple consecutive donnings on filtering facepiece
respirator fit. Am J Infect Control. 2012;40(4):375-80.
95. van Leeuwenhoeklaan A. Reuse of FFP2 Masks. Rijksinstituut voor
Voksgezondheid en Milieu. 18 March 2020.
96. Tsai PP. Information and FAQs on Performance, Protection, and
Sterilization of Masks Against COVID-19. 25 March 2020.
97. Ang B, Poh BF, Win MK, Chow A. Surgical masks for protection of
health care personnel against pandemic novel swine-origin influenza A
(H1N1)-2009: results from an observational study. Clin Infect Dis.
2010;50(7):1011-4.
98. Kantor J. Behavioral considerations and impact on personal
protective equipment (PPE) use: Early lessons from the coronavirus
(COVID-19) outbreak. J Am Acad Dermatol. 2020.
99. Suen LKP, Yang L, Ho SSK, Fung KHK, Boost MV, Wu CST, et al.
Reliability of N95 respirators for respiratory protection before,
during, and after nursing procedures. Am J Infect Control.
2017;45(9):974-8.
100. Roberts V. To PAPR or not to PAPR? Can J Respir Ther.
2014;50(3):87-90.
101. Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T,
et al. Possible SARS coronavirus transmission during cardiopulmonary
resuscitation. Emerg Infect Dis. 2004;10(2):287-93.
102. Wong DT. Protection protocol in intubation of suspected SARS
patients. Can J Anaesth. 2003;50(7):747-8.
103. Roberge MR, Vojtko MR, Roberge RJ, Vojtko RJ, Landsittel DP.
Wearing an N95 respirator concurrently with a powered air-purifying
respirator: effect on protection factor. Respir Care.
2008;53(12):1685-90.
104. Khoo KL, Leng PH, Ibrahim IB, Lim TK. The changing face of
healthcare worker perceptions on powered air-purifying respirators
during the SARS outbreak. Respirology. 2005;10(1):107-10.